References
- CarlingTUdelsmanRThyroid cancerAnnu Rev Med20146512513724274180
- CabanillasMEMcFaddenDGDuranteCThyroid cancerLancet2016388100612783279527240885
- WiltshireJJDrakeTMUttleyLBalasubramanianSPSystematic review of trends in the incidence rates of thyroid cancerThyroid201626111541155227571228
- Aragon HanPWengCHKhawajaHTMicroRNA expression and association with clinicopathologic features in papillary thyroid cancer: a systematic reviewThyroid201525121322132926414548
- HayesJPeruzziPPLawlerSMicroRNAs in cancer: biomarkers, functions and therapyTrends Mol Med201420846046925027972
- GarofaloMCroceCMmicroRNAs: master regulators as potential therapeutics in cancerAnnu Rev Pharmacol Toxicol201151254320809797
- Chrus´cikALamAKClinical pathological impacts of microRNAs in papillary thyroid carcinoma: a crucial reviewExp Mol Pathol201599339339826321247
- PengYLiCLuoDCDingJWZhangWPanGExpression profile and clinical significance of microRNAs in papillary thyroid carcinomaMolecules2014198115861159925100252
- TangJKongDCuiQBioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancerPeerJ20186e467429740512
- MazehHDeutchTKarasANext-generation sequencing identifies a highly accurate miRNA panel that distinguishes well-differentiated thyroid cancer from benign thyroid nodulesCancer Epidemiol Biomarkers Prev201827885886330049841
- LiSZhengHMaoAPRegulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6J Biol Chem201028574291429719996094
- ChenZJUbiquitination in signaling to and activation of IKKImmunol Rev201224619510622435549
- BommaritoARichiusaPCarissimiEBRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogyEndocr Relat Cancer201118666968521903858
- LvNShanZGaoYTwist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinomaEndocrine201651346947726289126
- ŚlusarzAPulakatLThe two faces of miR-29J Cardiovasc Med (Hagerstown)201516748049025689084
- JiangHZhangGWuJHJiangCPDiverse roles of miR-29 in cancer (review)Oncol Rep20143141509151624573597
- HuangPMaoLFZhangZPDown-regulated miR-125a-5p promotes the reprogramming of glucose metabolism and cell malignancy by increasing levels of CD147 in thyroid cancerThyroid201828561362329634399
- DetreSSaclani JottiGDowsettMA “quickscore” method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomasJ Clin Pathol19954898768787490328
- ZhaoZWangLSongWReduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancerWorld J Surg Oncol20151310125889078
- KatoKNakajimaKUiAMuto-TeraoYOgiwaraHNakadaSFine-tuning of DNA damage-dependent ubiquitination by OTUB2 supports the DNA repair pathway choiceMol Cell201453461763024560272
- GorovetsDKannanKShenRIDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic gliomaClin Cancer Res20121892490250122415316
- LiuLWangJLiXMiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinomaBiochem Biophys Res Commun2015457462162625603050
- HuangCCaiZHuangMmiR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor αJ Clin Endocrinol Metab20151002E204E21325423566
- MaSJiaWNiSmiR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1Biochem Biophys Res Commun2018497118118629427661
- LimaCRGeraldoMVFuziwaraCSKimuraETSantosMFMiRNA-146b-5p upregulates migration and invasion of different papillary thyroid carcinoma cellsBMC Cancer20161610826883911
- WeiCSongHSunXmiR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4Oncol Rep201534121122026063221
- HeHWangNYiXTangCWangDLong non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinomaCell Biosci201776529214011
- WangXLiuSCaoLmiR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinomaOncotarget2017849865928660329156819
- SalatiSSalvestriniVCarrettaCDeregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cellsOncotarget2017830494514946928533480
- QiuWYangZFanYZhengQMicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2Oncotarget2016726399073991527223438
- YuDGreenBTollesonWHMicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cellsBiochem Pharmacol201598121522326296572
- YuDTollesonWHKnoxBModulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cellsBiochem Pharmacol201598467168026428001
- SuJLuELuLZhangCMiR-29a-3p suppresses cell proliferation in laryngocarcinoma by targeting prominin 1FEBS Open Bio201775645651
- CatanzaroGSabatoCRussoMLoss of miR-107, miR-181c and miR-29a-3p promote activation of notch2 signaling in pediatric high-grade gliomas (pHGGs)Int J Mol Sci201718122742
- BeckAVinikYShatz-AzoulayHOtubain 2 is a novel promoter of beta cell survival as revealed by siRNA high-throughput screens of human pancreatic isletsDiabetologia20135661317132623515685